Free Trial
Your Rate Never Goes Up! Save $100 a Year on MarketBeat All Access
Upgrade Now
Claim MarketBeat All Access Sale Promotion
NYSE:HNGE

Hinge Health (HNGE) Stock Price, News & Analysis

Hinge Health logo
$111.47 +1.54 (+1.40%)
Closing price 03:59 PM Eastern
Extended Trading
$112.50 +1.03 (+0.92%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Hinge Health Stock (NYSE:HNGE)

Advanced

Key Stats

Today's Range
$109.14
▼
$112.58
50-Day Range
$85.66
▼
$112.02
52-Week Range
$30.08
▼
$113.48
Volume
1.56 million shs
Average Volume
1.86 million shs
Market Capitalization
$8.99 billion
P/E Ratio
85.22
Dividend Yield
N/A
Price Target
$107.00
Consensus Rating
Moderate Buy

Company Overview

Hinge Health is a digital healthcare company focused on musculoskeletal (MSK) conditions, including back and joint pain. The company provides virtual care programs designed to help members manage pain, improve mobility and reduce the need for more costly or invasive treatments.

Its platform combines personalized exercise therapy, behavioral support, education and access to clinical professionals. Hinge Health also uses technologies such as motion-sensing wearable devices and artificial intelligence to help guide exercises, monitor progress and tailor care plans to individual needs.

Hinge Health primarily serves employers and health plans, which offer its programs to eligible members in the United States. The company was founded in 2015 and is led by co-founder and Chief Executive Officer Daniel Perez. Hinge Health began trading publicly on the New York Stock Exchange under the symbol HNGE in 2025.

AI Generated. May Contain Errors.

Hinge Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
50th Percentile Overall Score

HNGE MarketRank™: 
2.498012191885 of 5 stars

Hinge Health scored higher than 50% of companies evaluated by MarketBeat, and ranked 523rd out of 907 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Hinge Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.89, and is based on 1 strong buy rating, 15 buy ratings, 3 hold ratings, and no sell ratings.

  • Upside/Downside

    The consensus price target for Hinge Health is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Hinge Health has been the subject of 14 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Hinge Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Hinge Health are expected to grow by 8.80% in the coming year, from $1.25 to $1.36 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Hinge Health is 87.09, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.76.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Hinge Health is 87.09, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.67.

  • Price to Book Value per Share Ratio

    Hinge Health has a P/B Ratio of 49.32. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Hinge Health's valuation and earnings.
  • Percentage of Shares Shorted

    9.68% of the float of Hinge Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Hinge Health has a short interest ratio ("days to cover") of 3.33, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Hinge Health has recently increased by 31.09%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Hinge Health does not currently pay a dividend.

  • Dividend Growth

    Hinge Health does not have a long track record of dividend growth.

  • News Sentiment

    Hinge Health has a news sentiment score of 1.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.48 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Hinge Health this week, compared to 4 articles on an average week.
  • Search Interest

    Only 9 people have searched for HNGE on MarketBeat in the last 30 days. This is a decrease of -40% compared to the previous 30 days.
  • MarketBeat Follows

    9 people have added Hinge Health to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Hinge Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $95,632,761.00 in company stock.

  • Percentage Held by Insiders

    18.92% of the stock of Hinge Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Hinge Health has minimal institutional ownership at this time.

  • Read more about Hinge Health's insider trading history.
Receive HNGE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hinge Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HNGE Stock News Headlines

BofA Securities Adjusts Hinge Health Price Target to $130 From $110
Hinge Health: Strong Growth, But Too Much Is Priced In
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel
Three-panel image showing an office call center, a man doing resistance-band exercise via video telehealth session, and lab technicians analyzing medical scans.
3 Healthcare Stocks Showing Why the Sector Still Has Momentum (HNGE)
Oscar Health, Hinge Health, and Insmed post strong earnings and revenue growth in 2026, with analysts projecting further upside despite sector risks like Medicaid cuts and drug pricing pressure.
See More Headlines

HNGE Stock Analysis - Frequently Asked Questions

Hinge Health's stock was trading at $46.42 at the beginning of 2026. Since then, HNGE stock has increased by 140.1% and is now trading at $111.47.

Hinge Health Inc. (NYSE:HNGE) issued its quarterly earnings data on Tuesday, August, 4th. The company reported $0.59 EPS for the quarter, beating analysts' consensus estimates of $0.28 by $0.31. The firm's quarterly revenue was up 53.0% on a year-over-year basis.
Read the conference call transcript
.

Hinge Health's board initiated a share repurchase program on Wednesday, November 12th 2025, which authorizes the company to buy back $250,000,000 in shares, according to EventVestor. This means that the company could repurchase up to 7.2% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's management believes its stock is undervalued.

Hinge Health (HNGE) raised $410 million in an IPO on Thursday, May 22nd 2025. The company issued 13,666,000 shares at $28.00-$32.00 per share.

Top institutional shareholders of Hinge Health include Assenagon Asset Management S.A. (2.30%), Vista Investment Partners LLC (0.07%), Argent Capital Management LLC (0.04%) and Wedmont Private Capital (0.04%). Insiders that own company stock include Bessemer Venture Partners X L, James Pursley, James Budge, Gabriel MI Mecklenburg, Kristina M Leslie, Daniel Antonio Perez and Insight Holdings Group, Llc.
View institutional ownership trends
.

Shares of HNGE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Hinge Health investors own include NVIDIA (NVDA), Micron Technology (MU), Advanced Micro Devices (AMD), Credo Technology Group (CRDO), Bloom Energy (BE), CrowdStrike (CRWD) and Datadog (DDOG).

Company Calendar

Last Earnings
8/04/2026
Today
10/23/2026
Next Earnings (Confirmed)
11/02/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NYSE:HNGE
Previous Symbol
NYSE:HNGE
CIK
1673743
Fax
N/A
Employees
1,437
Year Founded
2014

Price Target and Rating

High Price Target
$140.00
Low Price Target
$80.00
Potential Upside/Downside
-4.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.89
Research Coverage
19 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.28
Trailing P/E Ratio
87.09
Forward P/E Ratio
89.18
P/E Growth
N/A
Net Income
-$528.26 million
Net Margins
15.15%
Pretax Margin
15.41%
Return on Equity
51.60%
Return on Assets
14.16%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.34
Quick Ratio
1.30

Sales & Book Value

Annual Sales
$587.86 million
Price / Sales
15.30
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.26 per share
Price / Book
49.32

Miscellaneous

Outstanding Shares
80,690,000
Free Float
65,427,000
Market Cap
$8.99 billion
Optionable
Optionable
Beta
1.37

Social Links

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (NYSE:HNGE) was last updated on 10/23/2026 by MarketBeat.com Staff.
From Our Partners